New User? Sign Up Free
SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.
Mitchell Levy, MD, FCCM, discusses a perspectives article published in the October 19, 2006, issue of the New England Journal of Medicine, titled "Surviving Sepsis—Practice Guidelines, Marketing Campaigns, and Eli Lilly," which criticizes the campaign and its major funding source, Eli Lilly.
*If you are unable to play the podcast please click here to download the file.